FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022831340> ?p ?o ?g. }

• W2022831340 endingPage "3304" @default.
• W2022831340 startingPage "3294" @default.
• W2022831340 abstract "To estimate the excess risk of cardiovascular and cerebrovascular diseases among individuals with ankylosing spondylitis (AS) in Quebec compared with the general population of Quebec.A retrospective cohort study was conducted using population-based administrative data from Quebec. The cohort included all adult individuals with at least 1 AS diagnosis on physician billing or hospital discharge records between 1996 and 2006. A comparison cohort was generated using a 1% random sample of individuals without AS. Cardiovascular and cerebrovascular diseases, and associated hospitalizations, were classified into 1 of 6 subcategories: congestive heart failure, valvular (aortic or nonaortic) heart disease, ischemic heart disease, cerebrovascular disease, or other cardiovascular disease. The age- and sex-stratified prevalence estimates, and standardized prevalence ratios, of cardiovascular or cerebrovascular disease in patients with AS, compared to that in the general population, were calculated.The AS cohort included 8,616 individuals diagnosed over the period 1996-2006. The prevalence of cardiovascular and cerebrovascular diseases increased with increasing age for all cardiovascular disease subgroups, and was similar for individuals of both sexes. Age- and sex-stratified prevalence ratios were highest in younger individuals with AS. The age- and sex-standardized prevalence ratios comparing the risk among those with AS to the risk in the general population were as follows: for aortic valvular heart disease 1.58 (95% confidence interval [95% CI] 1.31-1.91), for nonaortic valvular heart disease 1.58 (95% CI 1.43-1.74), for ischemic heart disease 1.37 (95% CI 1.31-1.44), for congestive heart failure 1.34 (95% CI 1.26-1.42), for other cardiovascular disease 1.36 (95% CI 1.29-1.44), for cerebrovascular disease 1.25 (95% CI 1.15-1.35), and for any hospitalization for a cardiovascular or cerebrovascular disease 1.31 (95% CI 1.22-1.41).Compared with the general population, patients with AS are at increased risk for many types of cardiovascular and cerebrovascular diseases, and are more likely to be hospitalized for these diseases. The excess risk is greatest in younger patients with AS." @default.
• W2022831340 created "2016-06-24" @default.
• W2022831340 creator A5012746720 @default.
• W2022831340 creator A5037835747 @default.
• W2022831340 creator A5046535398 @default.
• W2022831340 creator A5053632288 @default.
• W2022831340 creator A5069979151 @default.
• W2022831340 creator A5078745837 @default.
• W2022831340 creator A5083588439 @default.
• W2022831340 date "2011-10-28" @default.
• W2022831340 modified "2023-10-14" @default.
• W2022831340 title "Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population-based study" @default.
• W2022831340 cites W1554203461 @default.
• W2022831340 cites W1557384345 @default.
• W2022831340 cites W1966756689 @default.
• W2022831340 cites W1971449009 @default.
• W2022831340 cites W1981448302 @default.
• W2022831340 cites W1985499121 @default.
• W2022831340 cites W1994703157 @default.
• W2022831340 cites W2003323453 @default.
• W2022831340 cites W2010846242 @default.
• W2022831340 cites W2012487908 @default.
• W2022831340 cites W2017103439 @default.
• W2022831340 cites W2018950002 @default.
• W2022831340 cites W2022386342 @default.
• W2022831340 cites W2035292279 @default.
• W2022831340 cites W2036641558 @default.
• W2022831340 cites W2038316924 @default.
• W2022831340 cites W2052531773 @default.
• W2022831340 cites W2054317822 @default.
• W2022831340 cites W2055019919 @default.
• W2022831340 cites W2059134831 @default.
• W2022831340 cites W2085567382 @default.
• W2022831340 cites W2087162507 @default.
• W2022831340 cites W2107176947 @default.
• W2022831340 cites W2111714917 @default.
• W2022831340 cites W2147109315 @default.
• W2022831340 cites W2153771220 @default.
• W2022831340 cites W2154309350 @default.
• W2022831340 cites W2166302161 @default.
• W2022831340 cites W2169389668 @default.
• W2022831340 cites W2170108033 @default.
• W2022831340 cites W2171017045 @default.
• W2022831340 cites W2171703670 @default.
• W2022831340 cites W2243268247 @default.
• W2022831340 cites W4237479246 @default.
• W2022831340 cites W4253588582 @default.
• W2022831340 doi "https://doi.org/10.1002/art.30581" @default.
• W2022831340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21834064" @default.
• W2022831340 hasPublicationYear "2011" @default.
• W2022831340 type Work @default.
• W2022831340 sameAs 2022831340 @default.
• W2022831340 citedByCount "177" @default.
• W2022831340 countsByYear W20228313402012 @default.
• W2022831340 countsByYear W20228313402013 @default.
• W2022831340 countsByYear W20228313402014 @default.
• W2022831340 countsByYear W20228313402015 @default.
• W2022831340 countsByYear W20228313402016 @default.
• W2022831340 countsByYear W20228313402017 @default.
• W2022831340 countsByYear W20228313402018 @default.
• W2022831340 countsByYear W20228313402019 @default.
• W2022831340 countsByYear W20228313402020 @default.
• W2022831340 countsByYear W20228313402021 @default.
• W2022831340 countsByYear W20228313402022 @default.
• W2022831340 countsByYear W20228313402023 @default.
• W2022831340 crossrefType "journal-article" @default.
• W2022831340 hasAuthorship W2022831340A5012746720 @default.
• W2022831340 hasAuthorship W2022831340A5037835747 @default.
• W2022831340 hasAuthorship W2022831340A5046535398 @default.
• W2022831340 hasAuthorship W2022831340A5053632288 @default.
• W2022831340 hasAuthorship W2022831340A5069979151 @default.
• W2022831340 hasAuthorship W2022831340A5078745837 @default.
• W2022831340 hasAuthorship W2022831340A5083588439 @default.
• W2022831340 hasConcept C126322002 @default.
• W2022831340 hasConcept C164705383 @default.
• W2022831340 hasConcept C167135981 @default.
• W2022831340 hasConcept C201903717 @default.
• W2022831340 hasConcept C2777402515 @default.
• W2022831340 hasConcept C2778198053 @default.
• W2022831340 hasConcept C2779736815 @default.
• W2022831340 hasConcept C2780074459 @default.
• W2022831340 hasConcept C2908647359 @default.
• W2022831340 hasConcept C71924100 @default.
• W2022831340 hasConcept C72563966 @default.
• W2022831340 hasConcept C99454951 @default.
• W2022831340 hasConceptScore W2022831340C126322002 @default.
• W2022831340 hasConceptScore W2022831340C164705383 @default.
• W2022831340 hasConceptScore W2022831340C167135981 @default.
• W2022831340 hasConceptScore W2022831340C201903717 @default.
• W2022831340 hasConceptScore W2022831340C2777402515 @default.
• W2022831340 hasConceptScore W2022831340C2778198053 @default.
• W2022831340 hasConceptScore W2022831340C2779736815 @default.
• W2022831340 hasConceptScore W2022831340C2780074459 @default.
• W2022831340 hasConceptScore W2022831340C2908647359 @default.
• W2022831340 hasConceptScore W2022831340C71924100 @default.
• W2022831340 hasConceptScore W2022831340C72563966 @default.
• W2022831340 hasConceptScore W2022831340C99454951 @default.
• W2022831340 hasIssue "11" @default.

• next